Accelerate Diagnostics (NASDAQ:AXDX) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Accelerate Diagnostics missed estimated earnings by 21.43%, reporting an EPS of $-0.17 versus an estimate of $-0.14.
Revenue was down $146 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 41.49% increase in the share price the next day.
Here’s a look at Accelerate Diagnostics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.19 | -0.28 | -0.30 |
| EPS Actual | -0.15 | -0.18 | -0.23 | -0.25 |
| Revenue Estimate | 2.87M | 3.75M | 3.00M | 2.95M |
| Revenue Actual | 2.97M | 2.96M | 3.86M | 2.96M |
To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
